Literature DB >> 27648338

Skeletal Muscle Metastases to the Flexor Digitorum Superficialis and Profundus from Urothelial Cell Carcinoma and Review of the Literature.

Marco Guidi1, Cesare Fusetti2, Stefano Lucchina1.   

Abstract

Urothelial cell carcinoma (UCC) metastases to skeletal muscle are extremely rare and usually found in patients with advanced stage cancer. The most common sites of bladder cancer metastases are lymph nodes, lung, liver, and bones. Muscle is an unusual site of metastases from a distant primary cancer, due to several protective factors. We present a rare case of 76-year-old patient with metastases in the flexor digitorum superficialis (FDS) and flexor digitorum profundus (FDP) muscles, 2 years after a radical cystectomy for invasive UCC of the bladder. This case is the first description of a forearm lesion, with an extensive infiltration of the volar compartments of the forearm, and the first one with a clear functional impairment.

Entities:  

Year:  2016        PMID: 27648338      PMCID: PMC5018329          DOI: 10.1155/2016/2387501

Source DB:  PubMed          Journal:  Case Rep Urol


1. Introduction

UCC is the most common primary malignancy of the urinary tract, accounting for more than 90% of all bladder cancers, and may affect its entire length, from renal pelvis to bladder [1]. UCC is usually a tumor of older patients, with the average age of presentation of 65 years, with a strong male predilection (M : F = 4 : 1) [1]. Skeletal muscle metastases from bladder cancer are very rare. In the English literature, only five studies reported [2-6] on skeletal muscle metastases from UCC with clinical-radiological findings. The case that we present is the first report of metastases involving the FDS and FDP muscles after an invasive UCC of the bladder. The authors have obtained the patient's informed written consent for print and electronic publication of the case report.

2. Case Report

A 76-year-old male presented to the general practitioner with gross hematuria and urinary frequency. The ultrasound (US) imaging and the cystoscopy revealed a mass in the bladder. A transurethral resection was undertaken and an invasive carcinoma (T3, N0, and M0) was found at the histological examination. Three cycles of neoadjuvant chemotherapy were performed with cisplatin and gemcitabine. Four months later, a radical cystectomy and an ileal conduit urinary diversion were performed. 1 year after, a complete thoracoabdominal computed tomography (CT) was negative for metastases. 18 months later, the patient presented a persistent anterior right forearm pain, resistant to analgesic, at first underestimated by the general practitioner and treated as tendonitis. The patient was referred to our hand surgery unit six months later for persistent pain of the right forearm and a painful flexion contracture of the proximal interphalangeal joints of the fingers (Figure 1) with the clinical suspicion of chronic compartment syndrome.
Figure 1

Clinical presentation of the flexion contracture of the fingers of the right hand.

The consequent clenched fist position was not passively reducible. Spasticity was also supposed, but there was no evidence of hyperactive response to quick stretch of the long fingers [7]. The Magnetic Resonance Imaging (MRI) revealed an irregular ring-enhancing lesion of 7.5 cm × 2.7 cm × 2.1 cm in the superficial and deep volar compartment of the forearm (Figure 2). The lesion was infiltrating the muscular body of the FDS and FDP.
Figure 2

MRI of the right forearm ((a), coronal view; (b), axial view): infiltrating lesion of the superficial and deep volar compartment of the forearm with a widespread edema.

A surgical explorative excision (Figure 3) of the lesion was performed with a resection en bloc of the FDS of the long fingers. The deep infiltration of the FDP and partially of the median nerve avoided a radical primary resection.
Figure 3

Intraoperative findings. ∗: Flexor digitorum superficialis partially resected; PL: palmaris longus; FPL: flexor pollicis longus; M: median nerve; FDP: flexor digitorum profundus.

The pathology reported a skeletal muscle metastasis compatible with a high grade UCC positive to the CK7, p63, GATA3, and AE1/AE3 markers and negative to the CK20 (Figures 4 and 5).
Figure 4

Nests of polygonal cells surrounded by stroma reaction of transitional cell carcinoma (arrow: mitotic figure), higher magnification. H&E ×200.

Figure 5

Immunohistochemistry: CK7, p63, and GATA3 expression in malignant cells, consistent with transitional cell differentiation.

A Pet/CT whole body (Figure 6) showed a metastatic progression of the cancer, with ectopic lesions to the right forearm, the left sacroiliac joint, and the chest wall.
Figure 6

A Pet/CT whole body showed an advanced stage of the cancer, with multiple metastasis in the right forearm and in the left sacroiliac joint and the chest wall.

For a local pain control, a palliative chemotherapy was administered with carboplatin and gemcitabine. Then, 5 cycles of 4 Gy radiotherapy were performed in the forearm (20 Gy). At 4 months postoperatively, the patient showed a recalcitrant flexion contracture of the long fingers without local pain in the right forearm. Five months after the surgical excision, the patient died due to the progressive deterioration of the general conditions.

3. Discussion

Metastases to the skeletal muscle from distant primary lesions are rare and usually found in case of advanced stage of cancer. Muscles are an unusual site of metastases even though they represent almost 50% of the total body mass [3] and are highly vascularized [4]. Several defensive factors have been proposed to create a hostile environment against metastases such as muscle pH, muscle motion, and ability to remove lactic acid accumulation that plays a role against tumor neovascularity [6-8]. Magee and Rosenthal [9] in 2002 reported that a previously documented local trauma seems to be a risk factor for development of metastasis, probably for an imbalance of local physiological and mechanical factors. Several studies from autopsies report rates of muscle metastases oscillating from 6% to 17,5% [10, 11]. These data underline the frequency of asymptomatic skeletal muscles metastases, most of all in advanced stage of a malignancy. The majority of these metastases are microscopic lesion undetectable with CT scans and MRI [4, 5]. Skeletal muscles metastases from UCC are, however, very rare and to our best knowledge, only 9 cases have been reported in the English literature [2-6]. The great muscles, such as the erector spinae, psoas, and gluteals, are the most common sites of metastatic involvement (Table 1). Nabi et al. [3] reported metastases to psoas, rectus abdominis, and adductor of the thigh. Doo et al. [5] and Katafigiotis et al. [6] described two metastases to sartorius, while Nagao et al. [4] proposed the case of one in the gluteus maximus.
Table 1
NumberStudyAgeInitial stage of diseaseInitial treatment receivedClinical presentationRadiological presentation: localisationTreatment receivedFollow-up
1Nabi et al. [3]65T3N0M0Radical cystectomy with sigmoid neobladderLocalized swelling on medial aspect of thigh with painCT showing ring-enhancing lesion in the left adductor of the thighPalliative chemotherapyDied at 8 months

2Nabi et al. [3]27T3BN2M0Radical cystectomy with ileal conduitPersistent back ache with limpCT with enlarged swollen left psoasPalliative chemotherapy with localized radiotherapyDied at 6 months

3Nabi et al. [3]62T3AN0M0Radical cystectomy with sigmoid neobladderPersistent swelling in anterior abdominal wallCT showing ring-enhancing lesion in left rectus abdominisPalliative chemotherapyDied at 12 months

4Nabi et al. [3]70T3BN2M1NoneLeft limp with backacheCT with enlarged swollen left psoasPalliative chemotherapy with localized radiotherapyDied at 8 months

5Nabi et al. [3]36T3AN1M0Radical cystectomy with ileal conduitPain in the backCT with swollen left psoas with areas of low attenuationsPalliative chemotherapyDied at 6 months

6Doo et al. [5]45T2N0M0Transurethral resectionLeft tight painMRI: T1 slight high signal, T2 high signal with strong enhancement in left sartoriusPalliative chemotherapy with localized radiotherapyNo data available

7Katafigiotis et al. [6]51T2N0M0Radical cystectomy and prostatectomy an urinary diversion with ileal conduitLeft tight pain and localized massMRI: no data available. Left sartoriusResection, radiotherapy, chemotherapyAlive at 7 months

8Ekici et al. [2]41T3N0M0ChemotherapyFixed mass on the deltoid muscle, painlessMRI: no data available. Right deltoid muscleResection, chemotherapyDied at 9 weeks

9 Nagao et al. [4]63T3N1M1Chemotherapy and radiotherapySwelling localized on the right gluteusCt with slight enhancement, gluteus maximusNo data availableNo data available

10Fusetti, Guidi, Lucchina76T3N0M0Radical cystectomy with ileal conduitPainful flexion contracture of the proximal interphalangeal joints of the fingersMRI: T2 high signal with strong enhancement of theflexor digitorum superficialis and profundusResection, chemotherapyDied at 5 months
Ekici et al. [2] described the first case of upper limb metastasis in a deltoid muscle. Our case is the first description of a forearm lesion, with an extensive infiltration of the volar compartments of the forearm, and the first one with a clear functional impairment. Usually, the clinical presentation of all the reported cases in literature [2-6] is a localized and painful muscular swelling (Table 1). In our case, the patient complained of a bothersome flexion contraction of the fingers with muscular pain, at first assumed as chronic compartment syndrome.

3.1. Radiologic Exams

Ekici et al. [2] emphasize that every localized muscular mass in patients affected previously by transitional cell carcinoma should be considered to be a metastasis and should be investigated. Skeletal muscle metastases are frequently incidental findings on CT of the chest or abdomen. The CT scans show an increase in ring-shaped enhancement with hypoattenuation of the inner part. MRI findings, although not specific, show low to intermediate signal intensity in the T1-weighted image and uniform high-signal intensity in the T2-weighted image (Table 1).

3.2. Treatment

Fine-needle aspiration biopsy with ultrasonographic guidance should be advisable to determine skeletal muscle metastases from UCC. In our case, we removed the lesion en bloc for diagnosis and treatment, according to Ekici et al. [2] and Katafigiotis et al. [6] that reported good results in terms of pain control with en bloc excision. Nabi et al. [3] reported that the mean survival rate after receiving chemotherapy was 8 months (min 6–max 12), while Katafigiotis reported a survivorship of 7 months after chemotherapy and radiotherapy. Chemotherapy with or without the addition of local radiotherapy has been reported as an efficient treatment in skeletal muscle metastases [3-5]. In the study of Nabi et al. [3], all patients had palliative chemotherapy with mitomycin, vincristine, adriamycin, and cyclophosphamide. Ekici et al. [2] used cisplatin, methotrexate, and vinblastine. Katafigiotis et al. [6] administered 6 cycles of gemcitabine and cisplatin. In our case, a carboplatin and gemcitabine protocol has been adopted (Table 1). Nabi et al. [3] used in two patients a local palliative radiotherapy of 35 Gy. Our patient received 5 cycles of 4 Gy radiotherapy (20 Gy) with good pain control. Chemotherapy and radiotherapy are usually the preferred palliative treatment method. Surgical resection should be proposed in case of compressive effect of the metastasis, even though en bloc excision can improve pain control in painful muscle metastases [3, 5].

4. Conclusion

Muscular localized swelling and lumps in patients with positive clinical history for UCC need to be taken as possible skeletal metastases. Radiological findings and a biopsy may help to study the lesion and to determine the most suitable treatment.
  9 in total

1.  Incidence and type of pathologic alterations observed in muscle in a routine autopsy survey.

Authors:  C M PEARSON
Journal:  Neurology       Date:  1959-11       Impact factor: 9.910

2.  Gluteal muscular and sciatic nerve metastases in advanced urinary bladder carcinoma: case report.

Authors:  E Nagao; A Nishie; K Yoshimitsu; H Irie; Y Shioyama; S Naito; S Matsuura; H Honda
Journal:  Abdom Imaging       Date:  2004-05-27

Review 3.  Transitional cell carcinoma of the pelvicalices and ureter.

Authors:  R A Leder; N R Dunnick
Journal:  AJR Am J Roentgenol       Date:  1990-10       Impact factor: 3.959

4.  Skeletal muscle metastases at sites of documented trauma.

Authors:  Thomas Magee; Howard Rosenthal
Journal:  AJR Am J Roentgenol       Date:  2002-04       Impact factor: 3.959

5.  Skeletal muscle metastasis from carcinoma of the bladder.

Authors:  S Ekici; H Ozen; G Gedikoglu; C Aygün
Journal:  Scand J Urol Nephrol       Date:  1999-10

6.  Skeletal muscle metastases from urothelial cell carcinoma.

Authors:  Seung Whan Doo; Woong Bin Kim; Bong Ki Kim; Won Jae Yang; Jong Hyun Yoon; Yun Seob Song; In Ho Choi
Journal:  Korean J Urol       Date:  2012-01-25

7.  Skeletal muscle metastasis from transitional cell carcinoma of the urinary bladder: clinicoradiological features.

Authors:  G Nabi; N P Gupta; D Gandhi
Journal:  Clin Radiol       Date:  2003-11       Impact factor: 2.350

8.  Metastatic carcinoma to skeletal muscle. A report of 15 patients.

Authors:  C L Herring; J M Harrelson; S P Scully
Journal:  Clin Orthop Relat Res       Date:  1998-10       Impact factor: 4.176

9.  Metastasis to sartorius muscle from a muscle invasive bladder cancer.

Authors:  Ioannis Katafigiotis; Antonios Athanasiou; Panagiotis K Levis; Evangelos Fragkiadis; Stavros Sfoungaristos; Achilles Ploumidis; Adamantios Michalinos; Christos Alamanis; Evangelos Felekouras; Constantinos A Constantinides
Journal:  Case Rep Med       Date:  2014-12-23
  9 in total
  2 in total

1.  Images - Isolated forearm soft tissue metastasis from bladder cancer.

Authors:  Cameron Gregory Ashe; Scott Bagnell; Samantha Gray
Journal:  Can Urol Assoc J       Date:  2018-08-30       Impact factor: 1.862

2.  Skeletal Muscle Metastasis to Vastus Lateralis from a Urothelial Carcinoma: A Case Report and Review of Its Diagnosis and Management.

Authors:  A M Mainwaring; H Wells; T Banks; T Ellul; P Bose
Journal:  Case Rep Urol       Date:  2019-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.